168 related articles for article (PubMed ID: 30551686)
1. Polyurethanes as New Excipients in Nail Therapeutics.
Valdes BSG; Serro AP; Marto J; Santos RGD; Gómez EC; Otero-Espinar FJ; Bordado JM; Ribeiro HM
Pharmaceutics; 2018 Dec; 10(4):. PubMed ID: 30551686
[TBL] [Abstract][Full Text] [Related]
2. New Polyurethane Nail Lacquers for the Delivery of Terbinafine: Formulation and Antifungal Activity Evaluation.
Gregorí Valdes BS; Serro AP; Gordo PM; Silva A; Gonçalves L; Salgado A; Marto J; Baltazar D; Dos Santos RG; Bordado JM; Ribeiro HM
J Pharm Sci; 2017 Jun; 106(6):1570-1577. PubMed ID: 28263845
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
Täuber A; Müller-Goymann CC
Mol Pharm; 2014 Jul; 11(7):1991-6. PubMed ID: 24490976
[TBL] [Abstract][Full Text] [Related]
4. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Drug Permeation from 8% Ciclopirox Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers.
Cutrín-Gómez E; Conde-Penedo A; Anguiano-Igea S; Gómez-Amoza JL; Otero-Espinar FJ
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32151015
[TBL] [Abstract][Full Text] [Related]
6. Onychomycosis: Potential of Nail Lacquers in Transungual Delivery of Antifungals.
Akhtar N; Sharma H; Pathak K
Scientifica (Cairo); 2016; 2016():1387936. PubMed ID: 27123362
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
8. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
Khattab A; Shalaby S
AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
[TBL] [Abstract][Full Text] [Related]
9. Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.
Tabara K; Szewczyk AE; Bienias W; Wojciechowska A; Pastuszka M; Oszukowska M; Kaszuba A
Postepy Dermatol Alergol; 2015 Feb; 32(1):40-5. PubMed ID: 25821426
[TBL] [Abstract][Full Text] [Related]
10. Onychomycosis due to Neoscytalidium treated with oral terbinafine, ciclopirox nail lacquer and nail abrasion: a pilot study of 25 patients.
Cursi ÍB; Silva RT; Succi IB; Bernardes-Engemann AR; Orofino-Costa R
Mycopathologia; 2013 Feb; 175(1-2):75-82. PubMed ID: 22976905
[TBL] [Abstract][Full Text] [Related]
11. Development of ciclopirox nail lacquer with enhanced permeation and retention.
Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
[TBL] [Abstract][Full Text] [Related]
12. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
Gupta AK; Fleckman P; Baran R
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
[TBL] [Abstract][Full Text] [Related]
13. Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Pfister WR
Mycoses; 2009 Jan; 52(1):35-43. PubMed ID: 18498299
[TBL] [Abstract][Full Text] [Related]
14. Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis.
Shivakumar HN; Vaka SR; Madhav NV; Chandra H; Murthy SN
J Pharm Sci; 2010 Oct; 99(10):4267-76. PubMed ID: 20737634
[TBL] [Abstract][Full Text] [Related]
15. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.
Del Rosso JQ
J Clin Aesthet Dermatol; 2014 Jul; 7(7):10-8. PubMed ID: 25053979
[TBL] [Abstract][Full Text] [Related]
16. Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer: A Review of Its Use in Onychomycosis.
Piraccini BM; Iorizzo M; Lencastre A; Nenoff P; Rigopoulos D
Dermatol Ther (Heidelb); 2020 Oct; 10(5):917-929. PubMed ID: 32705532
[TBL] [Abstract][Full Text] [Related]
17. Topical and device-based treatments for fungal infections of the toenails.
Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
[TBL] [Abstract][Full Text] [Related]
18. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
Bohn M; Kraemer KT
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S57-69. PubMed ID: 11051135
[TBL] [Abstract][Full Text] [Related]
19. Effect on Nail Structure and Transungual Permeability of the Ethanol and Poloxamer Ratio from Cyclodextrin-Soluble Polypseudorotaxanes Based Nail Lacquer.
Cutrín-Gómez E; Anguiano-Igea S; Delgado-Charro MB; Gómez-Amoza JL; Otero-Espinar FJ
Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30208659
[TBL] [Abstract][Full Text] [Related]
20. In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Saettone MF; Mailland F
Drug Dev Ind Pharm; 2005 Jan; 31(1):11-7. PubMed ID: 15704853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
